ERBB2 and breast cancer: Erik Knutsen and colleagues conducted a study (Knutsen et al., 2022), they discovered that a noticeable correlation was observed in relation to the expression level of NEAT1-2 and the grade of breast cancer tumors, as well as the presence of human epidermal growth factor receptor 2 (HER2)-positive BC samples.